Micol Fornaroli

Holifya is the first scientific wellness platform that offers personalized nutrition and prevention solutions based on analytics of genetic data and medical history. We provide a solution for medical studios, nutritionists and wellness professionals who want to be more distinctive and offer more personalized diets and therapies to their patients, as well as corporations who want to offer a cutting-edge employee benefit.

Lupa redefines veterinary care with the worlds first AI-Powered Veterinary Operating System for veterinary enterprises. Powered by AI we optimize operational efficiency and elevate the quality of care. Lupa OS offers real-time integrations, robust cloud infrastructure, and an intuitive UI, providing veterinary professionals with everything they need to manage their practice efficiently and effectively.

Agora Labs is building the new real-time health data ecosystem. The platform solves privacy and data quality, so that researchers and engineers can deliver insights and products built on real-world evidence at scale. Agora is powering real-time, secure access to multi-modal, longitudinal health data – privacy guaranteed. We make real-world data accessible and seamlessly interconnected between hospitals, life science companies and AI developers to reduce the cost of data and fuel faster and safer innovation. We automatically curate, standardize and activate data for research and for developing AI systems in the clinical setting. Founded in 2022 by medical doctors, MIT scientists and cryptographers, Agora is a deep-tech company bridging ethics, AI, and medicine through the value of data.

StarTric is developing an innovative structural heart technology to treat the regurgitation of the tricuspid valve. StarTric is the first and only minimally invasive repair device, conceived as a transcatheter replica of the highly effective open surgery technique, the edge-to-edge Clover repair. History StarTric founders include Prof. Ottavio Alfieri, who contributed to cardiac surgery with his “Alfieri-stich” or “edge-to-edge” repair of the mitral valve, and Prof. Michele De Bonis: together they pioneered the Clover technique for the repair of the tricuspid valve. Building on this legacy, StarTric transcatheter device is designed to replicate the results of the Clover repair. Today StarTric has been extensively prototyped and successfully tested in in-vivo and ex-vivo pathological model, and final product development is ongoing. Need Tricuspid regurgitation (TR) is a serious and common cardiovascular disease: the tricuspid valve (TV), fails to close properly during systole. This results in a reduced oxygenation of the body, causing symptoms impacting QoL, and consequences such as atrial fibrillation, heart failure and death: with up to 85% mortality at 10-years after diagnosis. TR affects 0.4% of the whole population and 4% of that over 75 years old: about 70 million patients worldwide. Nonetheless, only less than 3% of patients are treated by open surgery because of its very high operational mortality (9%). Furthermore, recent first generation transcatheter devices, originally conceived for the mitral valve, showed limited efficacy and accessibility only for a small population of patients. Conversely StarTric, designed for the TV and based on a tricuspid surgery technique, aims to be at the forefront of next generation technologies, with the goal of being safe, effective, easy to use and personalised, so to be truly accessible to the vast population of TR patients. Disclaimer. StartTric is currently under development and not available for clinical use.

CDS | La tua casa della salute – Fondata nel 2013, CDS è un network di poliambulatori specialistici, diagnostici, odontoiatrici e fisiokinesiterapici nato con l’obiettivo di contribuire alla tutela del diritto alla salute e garantire ai cittadini un servizio sanitario di alta qualità e prenotazioni in tempi brevi. La società conta 33 strutture tra Liguria e Piemonte, impiega oltre 400 dipendenti e 450 medici ed eroga ogni anno quasi un milione di prestazioni sanitarie. Dal 2020 CDS è controllata da Italmobiliare, holding della famiglia Pesenti quotata nel segmento STAR di Borsa Italiana, che ha dato grande impulso al piano di sviluppo della società. Per maggiori informazioni è possibile visitare il sito www.cds.it o contattare i nostri Uffici Amministrativi al numero 010 8078641

Il Centro Diagnostico Italiano, attivo a Milano dal 1975, è una struttura sanitaria ambulatoriale a servizio completo orientata alla prevenzione, diagnosi e cura in regime di day hospital. È presente sul territorio lombardo attraverso un network di strutture, collocate in Milano, Corsico, Rho, Cernusco sul Naviglio, Corteolona, Pavia, Varese. Nel 2006 la sede di via Saint Bon a Milano ha ricevuto il prestigioso accreditamento da parte di Joint Commission International. Nel 2018 l’accreditamento è stato esteso a tutti i poliambulatori e al Centro di Fisioterapia e Riabilitazione Con oltre 1000 persone tra medici specialisti, tecnici sanitari, infermieri e impiegati, CDI serve ogni anno oltre 400mila pazienti.

Dedalus Group is the leading healthcare and diagnostic software provider in Europe, supporting globally the digital transformation of 7500 Healthcare Organisations and 5700 Labs and Diagnostic centres worldwide, processing its solutions for more than 540 millions of population worldwide. Dedalus offer supports the whole continuum of care, in every step and phase, offering open standards-based solutions serving each actor of the Healthcare Ecosystem to provide better care in a healthier planet. The patient and the person, as complex individual with several needs, is the end point of the Group’s activities and the ultimate beneficiary: for this reason, we are aware and very proud of doing a «special job». Life flows through our software, is our motto.

Holifya is the first scientific wellness platform that offers personalized nutrition and prevention solutions based on analytics of genetic data and medical history. We provide a solution for medical studios, nutritionists and wellness professionals who want to be more distinctive and offer more personalized diets and therapies to their patients, as well as corporations who want to offer a cutting-edge employee benefit.

FSI is the largest country-focused Private Equity fund manager in Europe with approximately €3 bn AuM. FSI invests in excellent mid-sized and large corporates, owned by Italian families and entrepreneurs, to support growth and consolidation also on international markets. Investments are structured mainly as partnership investments, with strong governance structures and a very active FSI role to drive value creation. FSI invests in companies with moderate or no financial leverage. FSIs investors include, among others, some of the largest Italian institutional investors, primary sovereign funds from the Middle East, Far East and Central Asia, but also asset managers, insurance companies and European banks, foundations and family offices of industrial groups.

Lupa redefines veterinary care with the worlds first AI-Powered Veterinary Operating System for veterinary enterprises. Powered by AI we optimize operational efficiency and elevate the quality of care. Lupa OS offers real-time integrations, robust cloud infrastructure, and an intuitive UI, providing veterinary professionals with everything they need to manage their practice efficiently and effectively.

Agora Labs is building the new real-time health data ecosystem. The platform solves privacy and data quality, so that researchers and engineers can deliver insights and products built on real-world evidence at scale. Agora is powering real-time, secure access to multi-modal, longitudinal health data – privacy guaranteed. We make real-world data accessible and seamlessly interconnected between hospitals, life science companies and AI developers to reduce the cost of data and fuel faster and safer innovation. We automatically curate, standardize and activate data for research and for developing AI systems in the clinical setting. Founded in 2022 by medical doctors, MIT scientists and cryptographers, Agora is a deep-tech company bridging ethics, AI, and medicine through the value of data.